innovation.org
Home | About Us | Site Map | Contact Us Search
Impact of Innovation Future of Innovation Stories of Innovation Inside Drug Discovery News Center Tools & Resources
Tools & Resources
New Medicines in Development
Personalized Medicine in Action
Partnership for Prescription Assistance
Sign Up for
our Newsletter:

Get our newsletter on the impact of new medicines and updates on what's new in innovation.

What Others are Saying

The Value of Medicines: What Others are Saying

“I am confident that if we recommit ourselves to discovery…if we have the vision to believe and invest in things unseen, then we can lead the world into a new future of peace and prosperity.”

- Barack Obama, President of the United States, December 2008

“The key to fixing America’s broken healthcare system is to measure the value of healthcare instead of its cost… Individualized medicine…can significantly improve the value we deliver to patients.”

– Denis A. Cortese, M.D., President and Chief Executive Officer, Mayo Clinic, 2009
”I firmly believe that we stand on the cusp of an unprecedented period of discovery and invention in the life sciences in which our understanding of human differences replaces the pursuit of generalized well-being as the main driver of medical progress… Our goal is to give doctors the ability to prescribe for individual patients – with a high level of confidence – the right dose of the right medicine at the right time.”
- Sidney Taurel, Former Chairman, Eli Lilly and Company, December 12, 2008


“Over the long run, few issues are as important to a nation’s long-term economic security and global standing as being a leader in moving life sciences forward.”

– Lawrence Summers, Current Director, National Economic Council, 2007


"Over the last century, the value of gains in life expectancy seen in the U.S. is greater than the total value of all the measured growth in our economic output. New drugs are no small part of this medical miracle. The reduction in U.S. mortality from cardiovascular disease alone has been valued at $1.5 trillion annually from 1970 to 1990."
- Mark McClellan, former FDA Commissioner and current CMS Administrator, speaking before the First International Colloquium on Generic Medicine, September 25, 2003.

"The share of drugs in future medical spending is likely to increase sharply. But even without full cures, drugs that greatly delay the onset and severity of major diseases will reduce expensive and unproductive time spent in hospitals, nursing homes, and under the care of family members...New drugs have the potential to cut the growth of medical spending sharply. It is crucial to take much better advantage of this potential."
- Gary S. Becker, University of Chicago Professor and 1992 Nobel laureate, in March 22, 2004 article in Business Week